Literature DB >> 11451498

Mechanism of the ultrasonic activation of micellar drug delivery.

A Marin1, M Muniruzzaman, N Rapoport.   

Abstract

The mechanism of the ultrasonic enhancement of the uptake of cytotoxic drugs, doxorubicin (DOX) and ruboxyl (Rb) by HL-60 cells from Pluronic micelles was studied. DOX and Rb sorption from either PBS or micellar Pluronic solutions is described by Langmuir-type isotherms characteristic of substrates with limited number of sorption centers. The sorption limits for Rb from PBS and Pluronic were considerably higher than those for DOX, presumably due to much higher Rb partitioning into cell membranes. The overall number of drug sorption centers for both drugs decreased in the presence of Pluronic implying the effect of Pluronic on the DNA conformation, which was confirmed by the electron paramagnetic resonance (EPR) experiments using Rb as a spin probe. Ultrasound increased drug uptake by the cells from PBS and Pluronic solutions. The fluorescence microscopy and flow cytometry experiments using fluorescently-labeled Pluronic showed that ultrasound enhanced both the intracellular uptake of Pluronic micelles and Pluronic trafficking into cell nuclei. A scheme is suggested that describes various equilibria controlling drug/cell interactions and effect of ultrasound on these equilibria. Under the action of ultrasound, the equilibrium between the micellar-encapsulated and free drug is shifted in the direction of free drug due to micelle perturbation; the equilibrium between extracellular and internalized drug is shifted to the intracellular drug due to the ultrasound-induced cellular changes that enhance the accessibility of various cellular structures to drug. An important advantage offered by ultrasound is that the same degree of the intracellular drug uptake may be achieved at a substantially lower drug concentration in the incubation medium.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11451498     DOI: 10.1016/s0168-3659(01)00363-7

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  9 in total

Review 1.  Ultrasonic drug delivery--a general review.

Authors:  William G Pitt; Ghaleb A Husseini; Bryant J Staples
Journal:  Expert Opin Drug Deliv       Date:  2004-11       Impact factor: 6.648

2.  The comet assay to determine the mode of cell death for the ultrasonic delivery of doxorubicin to human leukemia (HL-60 Cells) from Pluronic P105 micelles.

Authors:  Ghaleb A Husseini; Kim L O'Neill; William G Pitt
Journal:  Technol Cancer Res Treat       Date:  2005-12

Review 3.  Phase-shift, stimuli-responsive drug carriers for targeted delivery.

Authors:  Brian E O'Neill; Natalya Rapoport
Journal:  Ther Deliv       Date:  2011-09

4.  Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers.

Authors:  Zhonggao Gao; Heidi D Fain; Natalya Rapoport
Journal:  Mol Pharm       Date:  2004 Jul-Aug       Impact factor: 4.939

5.  Doxorubicin as a molecular nanotheranostic agent: effect of doxorubicin encapsulation in micelles or nanoemulsions on the ultrasound-mediated intracellular delivery and nuclear trafficking.

Authors:  Praveena Mohan; Natalya Rapoport
Journal:  Mol Pharm       Date:  2010-10-27       Impact factor: 4.939

6.  Distribution of doxorubicin in rats undergoing ultrasonic drug delivery.

Authors:  Bryant J Staples; William G Pitt; Beverly L Roeder; Ghaleb A Husseini; Deepthi Rajeev; G Bruce Schaalje
Journal:  J Pharm Sci       Date:  2010-07       Impact factor: 3.534

Review 7.  Polymeric micelles in anticancer therapy: targeting, imaging and triggered release.

Authors:  Chris Oerlemans; Wouter Bult; Mariska Bos; Gert Storm; J Frank W Nijsen; Wim E Hennink
Journal:  Pharm Res       Date:  2010-08-20       Impact factor: 4.200

Review 8.  The use of ultrasound and micelles in cancer treatment.

Authors:  Ghaleb A Husseini; William G Pitt
Journal:  J Nanosci Nanotechnol       Date:  2008-05

Review 9.  Ultrasonic-activated micellar drug delivery for cancer treatment.

Authors:  Ghaleb A Husseini; William G Pitt
Journal:  J Pharm Sci       Date:  2009-03       Impact factor: 3.534

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.